Exchange: NASDAQ·Updated 07:44 PM EST

ICU News

News
all
press releases
SeaStar Reports Higher Survival In QUELIMMUNE Pediatric Kidney Injury Analysis
(RTTNews) - SeaStar Medical Holding Corp. (ICU) on Thursday said that critically ill pediatric patients with sepsis-associated acute kidney injury who received QUELIMMUNE (SCD-PED) therapy had significantly higher survival rates than a historical comparison group in the primary a...
Nasdaq News: Markets
SeaStar Reports Higher Survival In QUELIMMUNE Pediatric Kidney Injury Analysis
(RTTNews) - SeaStar Medical Holding Corp. (ICU) on Thursday said that critically ill pediatric patients with sepsis-associated acute kidney injury who received QUELIMMUNE (SCD-PED) therapy had significantly higher survival rates than a historical comparison group in the primary a...
Nasdaq News: Markets
More News
Shares of SeaStar Medical Holding Corporation (NASDAQ: ICU) are trading lower Friday after the company initiated a reverse stock split.read more...
Benzinga
The trial’s enrollment target has been raised to 339 patients, with completion expected by late 2026.
Stocktwits
The public offer price of $0.65 represents a 33% discount on the stock’s closing price on Wednesday.
Stocktwits

Advertisement|Remove ads.